+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Facial Injectable Market Size, Share & Industry Trends Analysis Report By End-use (MedSpa, Dermatology Clinics and Hospitals), By Product, By Application, By Country and Growth Forecast, 2023 - 2029

  • PDF Icon

    Report

  • 89 Pages
  • May 2023
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5833818
The Europe Facial Injectable Market should witness market growth of 9.4% CAGR during the forecast period (2023-2029).

The existence of well-known main players like Allergan, Sinclair Pharma, and Galderma with extensive injectable filler product portfolios treating a variety of skin indications like pigmentation, wrinkles, lip enhancement, scar reduction, and restoring facial fullness. Additionally, improving facial features is anticipated to fuel demand for this procedure and thus increase market revenue. Furthermore, during the projected period, the market is anticipated to be driven by growing social media exposure, rising facial injectable effectiveness & approvals, and an increasing need among people everywhere to seem young and attractive.

The rise in plastic surgeons and their networks is fueling the need for cosmetic operations, which in turn is boosting the market. In addition, due to the high number of patients seeking facial reconstruction following dental surgeries, healthcare professionals can now undertake facial injectable procedures. This element will probably lead to the growth of the facial injectable market.

In Spain, cosmetic operations are growing in popularity. The nation's economy and the citizens' disposable money are the two main variables affecting the rates of plastic surgery in a nation. Greece is a very affluent nation with an income that allows for the luxury of cosmetic surgery. Additionally, the availability of advanced healthcare infrastructure with a high level of public awareness about cosmetic treatments has caused a notable rise in the number of procedures, accelerating the regional market for face injectables' quick expansion.

The Germany market dominated the Europe Facial Injectable Market by Country in 2022 thereby, achieving a market value of $1,414.9 Million by 2029. The UK market is registering a CAGR of 8.5% during (2023-2029). Additionally, The France market would showcase a CAGR of 10.2% during (2023-2029).

Based on End-use, the market is segmented into MedSpa, Dermatology Clinics and Hospitals. Based on Product, the market is segmented into Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid (PLLA), Collagen & PMMA Microspheres, Hyaluronic Acid (HA) and Others. Based on Application, the market is segmented into Facial Line Correction, Face Lift, Lip Augmentation, Acne Scar Treatment, Lipoatrophy Treatment and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Ipsen Pharma Biotech SAS, Merz Pharma GmbH & Co. KGaA, Suneva Medical, Inc., Medytox Inc., Sinclair Pharma Ltd., Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group), Anika Therapeutics, Inc., Prollenium Medical Technologies Inc., Galderma S.A., and Allergan PLC (AbbVie, Inc.).

Scope of the Study

By End-use

  • MedSpa
  • Dermatology Clinics
  • Hospitals

By Product

  • Botulinum Toxin Type A
  • Calcium Hydroxylapatite (CaHA)
  • Poly-L-Lactic Acid (PLLA)
  • Collagen & PMMA Microspheres
  • Hyaluronic Acid (HA)
  • Others

By Application

  • Facial Line Correction
  • Face Lift
  • Lip Augmentation
  • Acne Scar Treatment
  • Lipoatrophy Treatment
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Ipsen Pharma Biotech SAS
  • Merz Pharma GmbH & Co. KGaA
  • Suneva Medical, Inc.
  • Medytox Inc.
  • Sinclair Pharma Ltd.
  • Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group)
  • Anika Therapeutics, Inc.
  • Prollenium Medical Technologies Inc.
  • Galderma S.A.
  • Allergan PLC (AbbVie, Inc.)

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Facial Injectable Market, by End-use
1.4.2 Europe Facial Injectable Market, by Product
1.4.3 Europe Facial Injectable Market, by Application
1.4.4 Europe Facial Injectable Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Facial Injectable Market by End-use
3.1 Europe MedSpa Market by Country
3.2 Europe Dermatology Clinics Market by Country
3.3 Europe Hospitals Market by Country
Chapter 4. Europe Facial Injectable Market by Product
4.1 Europe Botulinum Toxin Type A Market by Country
4.2 Europe Calcium Hydroxylapatite (CaHA) Market by Country
4.3 Europe Poly-L-Lactic Acid (PLLA) Market by Country
4.4 Europe Collagen & PMMA Microspheres Market by Country
4.5 Europe Hyaluronic Acid (HA) Market by Country
4.6 Europe Others Market by Country
Chapter 5. Europe Facial Injectable Market by Application
5.1 Europe Facial Line Correction Market by Country
5.2 Europe Face Lift Market by Country
5.3 Europe Lip Augmentation Market by Country
5.4 Europe Acne Scar Treatment Market by Country
5.5 Europe Lipoatrophy Treatment Market by Country
5.6 Europe Others Market by Country
Chapter 6. Europe Facial Injectable Market by Country
6.1 Germany Facial Injectable Market
6.1.1 Germany Facial Injectable Market by End-use
6.1.2 Germany Facial Injectable Market by Product
6.1.3 Germany Facial Injectable Market by Application
6.2 UK Facial Injectable Market
6.2.1 UK Facial Injectable Market by End-use
6.2.2 UK Facial Injectable Market by Product
6.2.3 UK Facial Injectable Market by Application
6.3 France Facial Injectable Market
6.3.1 France Facial Injectable Market by End-use
6.3.2 France Facial Injectable Market by Product
6.3.3 France Facial Injectable Market by Application
6.4 Russia Facial Injectable Market
6.4.1 Russia Facial Injectable Market by End-use
6.4.2 Russia Facial Injectable Market by Product
6.4.3 Russia Facial Injectable Market by Application
6.5 Spain Facial Injectable Market
6.5.1 Spain Facial Injectable Market by End-use
6.5.2 Spain Facial Injectable Market by Product
6.5.3 Spain Facial Injectable Market by Application
6.6 Italy Facial Injectable Market
6.6.1 Italy Facial Injectable Market by End-use
6.6.2 Italy Facial Injectable Market by Product
6.6.3 Italy Facial Injectable Market by Application
6.7 Rest of Europe Facial Injectable Market
6.7.1 Rest of Europe Facial Injectable Market by End-use
6.7.2 Rest of Europe Facial Injectable Market by Product
6.7.3 Rest of Europe Facial Injectable Market by Application
Chapter 7. Company Profiles
7.1 Ipsen Pharma Biotech SAS
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.2 Merz Pharma GmbH & Co. KGaA
7.2.1 Company Overview
7.2.2 Recent Strategies and Developments
7.2.2.1 Partnerships, Collaborations, and Agreements
7.2.2.2 Product Launches and Product Expansions
7.3 Suneva Medical, Inc.
7.3.1 Company Overview
7.4 Medytox Inc.
7.4.1 Company Overview
7.5 Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
7.5.1 Company Overview
7.5.2 Recent Strategies and Developments
7.5.2.1 Product Launches and Product Expansions
7.5.2.2 Approvals and Trials
7.6 Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group)
7.6.1 Company Overview
7.7 Anika Therapeutics, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Prollenium Medical Technologies Inc.
7.8.1 Company Overview
7.8.2 Recent Strategies and Developments
7.8.2.1 Acquisition and Mergers
7.9 Galderma S.A.
7.9.1 Company Overview
7.9.2 Recent Strategies and Developments
7.9.2.1 Partnerships, Collaborations, and Agreements
7.9.2.2 Acquisition and Mergers
7.10. Allergan PLC (AbbVie, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expense

Companies Mentioned

  • Ipsen Pharma Biotech SAS
  • Merz Pharma GmbH & Co. KGaA
  • Suneva Medical, Inc.
  • Medytox Inc.
  • Sinclair Pharma Ltd.
  • Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group)
  • Anika Therapeutics, Inc.
  • Prollenium Medical Technologies Inc.
  • Galderma S.A.
  • Allergan PLC (AbbVie, Inc.)

Methodology

Loading
LOADING...